Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal risk prediction for pediatric glioma with temporal deep learning.
Tak D, Garomsa BA, Zapaishchykova A, Ye Z, Vajapeyam S, Mahootiha M, Climent Pardo JC, Smith C, Familiar AM, Chaunzwa T, Liu KX, Prabhu S, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Haas-Kogan D, Poussaint TY, Kann BH. Tak D, et al. medRxiv [Preprint]. 2024 Jun 28:2024.06.04.24308434. doi: 10.1101/2024.06.04.24308434. medRxiv. 2024. PMID: 38978642 Free PMC article. Preprint.
Leptomeningeal metastatic disease: new frontiers and future directions.
Ozair A, Wilding H, Bhanja D, Mikolajewicz N, Glantz M, Grossman SA, Sahgal A, Le Rhun E, Weller M, Weiss T, Batchelor TT, Wen PY, Haas-Kogan DA, Khasraw M, Rudà R, Soffietti R, Vollmuth P, Subbiah V, Bettegowda C, Pham LC, Woodworth GF, Ahluwalia MS, Mansouri A. Ozair A, et al. Among authors: haas kogan da. Nat Rev Clin Oncol. 2024 Dec 9. doi: 10.1038/s41571-024-00970-3. Online ahead of print. Nat Rev Clin Oncol. 2024. PMID: 39653782 Review.
Editor's Note: BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss W, Resnick AC, Waanders AJ, Stalpers LJA, Berger MS, Gupta N, James CD, Petritsch CK, Haas-Kogan DA. Olow A, et al. Among authors: haas kogan da. Clin Cancer Res. 2024 Dec 2;30(23):5494. doi: 10.1158/1078-0432.CCR-24-3478. Clin Cancer Res. 2024. PMID: 39618199 No abstract available.
When Best Care Takes a Back Seat to the Bottom Line.
Leeman JE, Han Z, Haas-Kogan DA. Leeman JE, et al. Among authors: haas kogan da. JAMA Oncol. 2024 Oct 1;10(10):1311-1312. doi: 10.1001/jamaoncol.2024.2485. JAMA Oncol. 2024. PMID: 39088197
Stepwise Transfer Learning for Expert-level Pediatric Brain Tumor MRI Segmentation in a Limited Data Scenario.
Boyd A, Ye Z, Prabhu SP, Tjong MC, Zha Y, Zapaishchykova A, Vajapeyam S, Catalano PJ, Hayat H, Chopra R, Liu KX, Nabavizadeh A, Resnick AC, Mueller S, Haas-Kogan DA, Aerts HJWL, Poussaint TY, Kann BH. Boyd A, et al. Among authors: haas kogan da. Radiol Artif Intell. 2024 Jul;6(4):e230254. doi: 10.1148/ryai.230254. Radiol Artif Intell. 2024. PMID: 38984985 Free PMC article.
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field.
Liu KX, Shaaban SG, Chen JJ, Bagatell R, Lerman BJ, Catalano PJ, DuBois SG, Shusterman S, Ioakeim-Ioannidou M, Yock TI, Shamberger RC, Mattei P, Vu L, Elhalawani H, Dusenbery KE, Vo KT, Huang MS, Friedmann AM, Diller LR, Marcus KJ, MacDonald SM, Terezakis SA, Braunstein SE, Hill-Kayser CE, Haas-Kogan DA. Liu KX, et al. Among authors: haas kogan da. Radiother Oncol. 2024 Sep;198:110384. doi: 10.1016/j.radonc.2024.110384. Epub 2024 Jun 15. Radiother Oncol. 2024. PMID: 38880415
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.
Rahman R, Shi DD, Reitman ZJ, Hamerlik P, de Groot JF, Haas-Kogan DA, D'Andrea AD, Sulman EP, Tanner K, Agar NYR, Sarkaria JN, Tinkle CL, Bindra RS, Mehta MP, Wen PY. Rahman R, et al. Among authors: haas kogan da. Neuro Oncol. 2024 Aug 5;26(8):1367-1387. doi: 10.1093/neuonc/noae072. Neuro Oncol. 2024. PMID: 38770568 Review.
169 results